Evidence mapPaperPMID 38987458Full record

ArticleArchives of gynecology and obstetrics2024

Does the gestational age at which the glucose challenge test (GCT) is conducted influence the diagnosis of gestational diabetes mellitus (GDM)?

Ella Pardo, Yael Yagur, Hadar Gluska, Gal Cohen, Michal Kovo, Tal Biron-Shental, Omer Weitzner

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ella PardoDepartment of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St., 442816, Kfar Saba, Israel.ORCID http://orcid.org/0000-0002-4992-5026
Yael YagurDepartment of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St., 442816, Kfar Saba, Israel.ORCID http://orcid.org/0000-0002-3560-6374
Hadar GluskaDepartment of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St., 442816, Kfar Saba, Israel.ORCID http://orcid.org/0000-0003-2618-5448
Gal CohenDepartment of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St., 442816, Kfar Saba, Israel.ORCID http://orcid.org/0000-0001-7944-0532
Michal KovoDepartment of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St., 442816, Kfar Saba, Israel.ORCID http://orcid.org/0000-0002-5443-5670
Tal Biron-ShentalDepartment of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St., 442816, Kfar Saba, Israel.ORCID http://orcid.org/0000-0003-4665-7051
Omer WeitznerDepartment of Obstetrics and Gynecology, Meir Medical Center, 59 Tchernichovsky St., 442816, Kfar Saba, Israel. omer.w4@gmail.com.ORCID http://orcid.org/0000-0001-6176-4424

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study's objective is to investigate disparities in the rates of gestational diabetes mellitus (GDM) diagnosis, influenced by the timing of the glucose challenge test GCT.

methodsThis retrospective cohort study included women with singleton or twin pregnancies exhibiting abnormal GCT result between 24 and 28 weeks of gestation, followed by an oral glucose tolerance test OGTT during the same period. Data regarding pregnancy follow-up from patients' deliveries at a singular tertiary medical from 2014 to 2022 were retrieved. The probability of GDM diagnosis was stratified based on the gestational week of the GCT and the definition of a positive OGTT, delineated by one or two abnormal values.

resultsThe study included 636 women with abnormal GCT between 24 and 28 weeks of gestation. Of them, 157 unerwent the GCT between 24.0 and 24.6 weeks, 204 between 25.0 and 25.6 weeks, 147 between 26.0 and 26.6 weeks, and 128 between 27.0 and 28.6 weeks. We found that the highest incidence of GDM, defined by one or two pathological values of the OGTT, following the initial screening with a GCT, where abnormal results were defined as values exceeding 140 mg/dL, was diagnosed in patients who underwent GCT between 26.0 and 26.6 weeks of gestation. Conversely, the lowest rates were observed in patients screened between 24.0 and 24.6 weeks of gestation.

conclusionThe timing of screening for GDM using the GCT significantly affects the rate of diagnosis. Clinicians managing pregnancies should consider this data when formulating treatment plans.

Indexed as

Diabetes, GestationalGestational AgeGlucose Tolerance TestAdultBlood GlucoseCohort StudiesFemaleHumansPregnancyRetrospective StudiesBlood GlucoseGDM diagnosisGestational diabetes mellitusGlucose challenge testOral glucose tolerance test

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.